Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer

Expert Review of Pharmacoeconomics & Outcomes Research(2022)10.1080/14737167.2022.2044309Source: DataRank Database

Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer is a research paper published in Expert Review of Pharmacoeconomics & Outcomes Research (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.25)OA: greenTopics (53)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Rima Tawk ORCID,Hong Xiao ORCID,Anastasia Semykina ORCID,Alberto J. Montero ORCID,Richard K. Moussa ORCID

Live enrichment

PubMed:35189767 PMC:PMC10791147 OpenAlex:https://openalex.org/W4213119376

NCCDPHP CDC HHS

Grant: U58 DP003862

NCI NIH HHS

Grant: HHSN261201000035I

NIMHD NIH HHS

Grant: U54 MD007582

NCI NIH HHS

Grant: HHSN261201000035C

NIMHD NIH HHS

Grant: G12 MD007582

NCI NIH HHS

Grant: HHSN261201000034C

NCI NIH HHS

Grant: HHSN261201000140C

National Institutes of Health

Grant: 1U58DP003862-01

CALIFORNIA COORDINATED CANCER PREVENTION & CONTROL PROGRAM

National Institutes of Health

Grant: 2G12MD007582-29

FAMU RCMI Pharmaceutical Research Center

FWCI

0.25

Citation Percentile

0.4%

Citation Trend

2023

2024

greenLicense: cc-by

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10791147/pdf/nihms-1852057.pdf

publisherhttps://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2044309

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10791147

journalhttps://doi.org/10.1080/14737167.2022.2044309

Fields of Study

Breast Cancer Treatment StudiesBRCA gene mutations in cancerAdvances in Oncology and Radiotherapy03 medical and health sciences0302 clinical medicineAgedBreast NeoplasmsCost-Benefit AnalysisFemaleHumansMastectomy, SegmentalMedicareQuality-Adjusted Life YearsRetrospective StudiesUnited States

MeSH Terms

AgedBreast NeoplasmsCost-Benefit AnalysisFemaleMedicareHumansRetrospective StudiesUnited StatesMastectomy, SegmentalQuality-Adjusted Life Years

Keywords

MedicineBreast cancerRadiation therapyMedicaidHormonal therapyHormone therapyCost effectivenessOncologyHormone receptorInternal medicineGynecologyCancerHealth careRadiotherapyElderly WomenEarly-stage Breast CancerDoubly Robust EstimatorComparative Cost-effectivenessCost-Benefit AnalysisHumansBreast NeoplasmsFemaleQuality-Adjusted Life YearsMastectomy, SegmentalMedicareUnited StatesAgedRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer

10.6084/m9.figshare.19328843.v1Taylor & Francis

Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer

10.6084/m9.figshare.19328843Taylor & Francis